Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew N O'Brien Laramy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Delivery|August 1, 2022
Long-acting ocular drug delivery technologies with clinical precedentMatthew N O'Brien Laramy, Karthik Nagapudi
Nature Reviews. Drug Discovery|February 22, 2023
Delivering on the promise of protein degradersMatthew N O'Brien Laramy, Suman Luthra, Matthew F Brown, et al.
Molecular Pharmaceutics|December 20, 2025
Conformation-Dependent Complexation Interactions for a SMARCA2 PROTAC and CyclodextrinMatthew N O'Brien Laramy, José G Napolitano, Yuhui Zhou, et al.
Journal of Pharmaceutical Sciences|August 5, 2023
Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19Matthew N O'Brien Laramy, Padmavani Bezawada, Reto Horst, et al.
Molecular Pharmaceutics|July 18, 2023
Process Robustness in Lipid Nanoparticle Production: A Comparison of Microfluidic and Turbulent Jet MixingMatthew N O'Brien Laramy, Antonio P Costa, Yareli Maciel Cebrero, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Delivery|August 1, 2022
Long-acting ocular drug delivery technologies with clinical precedentMatthew N O'Brien Laramy, Karthik Nagapudi
Nature Reviews. Drug Discovery|February 22, 2023
Delivering on the promise of protein degradersMatthew N O'Brien Laramy, Suman Luthra, Matthew F Brown, et al.
Molecular Pharmaceutics|December 20, 2025
Conformation-Dependent Complexation Interactions for a SMARCA2 PROTAC and CyclodextrinMatthew N O'Brien Laramy, José G Napolitano, Yuhui Zhou, et al.
Journal of Pharmaceutical Sciences|August 5, 2023
Self-Assembly Properties of an Amphiphilic Phosphate Ester Prodrug Designed for the Treatment of COVID-19Matthew N O'Brien Laramy, Padmavani Bezawada, Reto Horst, et al.
Molecular Pharmaceutics|July 18, 2023
Process Robustness in Lipid Nanoparticle Production: A Comparison of Microfluidic and Turbulent Jet MixingMatthew N O'Brien Laramy, Antonio P Costa, Yareli Maciel Cebrero, et al.
Pageof 1